Redwood Scientific Technologies, Inc.
RSCI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.42K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $20,418.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.02 |
| Beta | -3.03 |
| Outstanding Shares | 204,177,134 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Redwood Scientific Technologies, Inc.
5 employees
CEO: Jason Cardiff
Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.